Esaxerenone Protects against Diabetic Cardiomyopathy via Inhibition of the Chemokine and PI3K-Akt Signaling Pathway.
- Resource Type
- Article
- Source
- Biomedicines; Dec2023, Vol. 11 Issue 12, p3319, 18p
- Subject
DIABETIC cardiomyopathy CELLULAR signal transduction MINERALOCORTICOID receptors GENE expression CHRONIC kidney failure - Language
- ISSN
- 22279059